NCT06024031Active, not recruitingPhase 2
NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy
N-acetyl-L-cysteine for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy--a Prospective Single-arm Clinical Study
Source: ClinicalTrials.gov · Last updated 7 Nov 2024
Brief summary (registry, in English)
This is a prospective single-arm clinical study to evaluate the role of NAC after chemotherapy among patients with AML can promote hematopoietic recovery and does not affect the remission rate of the leukemia.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 24 Aug 2023
- Start date
- 10 Sept 2023
- Primary completion date
- 1 Sept 2024
- Lead sponsor
- Peking University People's Hospital
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT06024031
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 30
- From 10 Sept 2023 to the primary completion date, 1 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hypersensitivity to NAC
- History of bronchial asthma
Who the study is looking for
- Newly diagnosed AML (except AML-M3)
- Low-, intermediate risk AML (according to 2022 ELN)
- Aged 18-60
- No severe organ injury 1) Creatinine \< 1.5mg/dl 2) Hemobilirubin ≤ 1.5 X ULN 3) AST and ALT ≤ 3.0 X ULN 4) Cardiac ejection index ≥ 50%
- No uncontrolled active infections
- Sign informed consent form, have the ability to comply with study and follow-up procedures
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yuan Kong Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.